×
About 17,983 results

ALLMedicine™ Proteinuria Center

Research & Reviews  5,916 results

Comparison of clinical, pathological and long-term renal outcomes of children with Heno...
https://doi.org/10.1007/s11255-021-03063-7 10.1007/s00296-016-3425-3 10.1007/s00467-017-3597-4 10.1007/s11695-017-2940-y
International Urology and Nephrology; Torun Bayram M, Heybeli C et. al.

Dec 1st, 2021 - To compare clinical, pathological, and long-term renal outcomes of children with Henoch-Schonlein purpura nephritis (HSPN) and IgA nephropathy (IgAN). The medical records of patients diagnosed as HSPN and IgAN during childhood were evaluated retro...

Effects of hydroxychloroquine on proteinuria in membranous nephropathy.
https://doi.org/10.1007/s40620-021-01182-z 10.1053/j.ajkd.2015.07.006 10.1056/NEJMoa0810457 10.1007/s40620-017-0451-5 10.1056/NEJMc1500130 10.1681/ASN.2018080852 10.1016/j.kint.2019.09.014 10.1016/j.kint.2020.05.030 10.1681/asn.2020081165 10.1016/j.kint.2020.09.016 10.2215/CJN.01920218 10.1093/ndt/gfr285 10.1038/kisup.2012.9 10.1681/ASN.2013020185 10.2215/CJN.01330209 10.1681/asn.2004121074 10.1007/s11739-019-02257-3 10.1038/s41584-020-0372-x 10.1080/14740338.2017.1269168 10.1038/nrrheum.2012.106 10.1191/0961203306lu2313oa 10.1177/0961203307086503 10.1093/ndt/gfx318 10.1177/0961203319890007 10.2215/cjn.03300318 10.2215/CJN.11781017 10.1007/s11255-017-1574-2 10.1053/j.ajkd.2019.01.026 10.1186/s12882-019-1488-6 10.7326/0003-4819-150-9-200905050-00006 10.1016/j.amjmed.2009.06.032 10.1093/ndt/17.8.1413 10.1046/j.1523-1755.2000.00880.x 10.1053/ajkd.2001.29262 10.1177/0961203313496339 10.1093/ndt/gfs122 10.1177/0961203314555352 10.1681/ASN.2010111125 10.1681/asn.2014070640 10.1681/asn.2016070776 10.1080/15548627.2018.1474314 10.1093/jac/dkv018 10.1016/j.kint.2019.07.014 10.1146/annurev-pathol-020117-043811 10.1182/blood-2011-01-329060 10.1371/journal.pone.0065913 10.3109/03009742.2014.922214 10.1016/j.kint.2017.01.012 10.1016/j.autrev.2016.02.014
Journal of Nephrology; Cheng YJ, Cheng XY et. al.

Dec 1st, 2021 - Many patients with primary membranous nephropathy have severe proteinuria unresponsive to optimized renin-angiotensin-aldosterone system inhibitors (RAASi). We evaluated the efficacy and safety of hydroxychloroquine as an adjunctive agent in membr...

Time-Varying Proteinuria and the Risk of Cardiovascular Disease and Graft Failure in Ki...
https://doi.org/10.1177/15269248211046011
Progress in Transplantation (Aliso Viejo, Calif.); Kuper T, Famure O et. al.

Nov 30th, 2021 - Introduction: Proteinuria is recognized as an independent risk factor for cardiovascular disease in kidney transplant recipients, but previous studies have not considered the impact of changes in urine protein over time. Research Question and Desi...

Maternal Perinatal Characteristics in Patients with Severe Preeclampsia: A Case-Control...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8623459
International Journal of Environmental Research and Publi... Aracil Moreno I, Rodríguez-Benitez P et. al.

Nov 28th, 2021 - Preeclampsia is one of the most worrisome complications during pregnancy, affecting approximately 1 out of 20 women worldwide. Preeclampsia is mainly characterized by a sustained hypertension, proteinuria, also involving a significant organ dysfun...

see more →

Guidelines  6 results

Management of congenital nephrotic syndrome: consensus recommendations of the ERKNet-ES...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8128706
Nature Reviews. Nephrology; Boyer O, Schaefer F et. al.

Jan 31st, 2021 - Congenital nephrotic syndrome (CNS) is a heterogeneous group of disorders characterized by nephrotic-range proteinuria, hypoalbuminaemia and oedema, which manifest in utero or during the first 3 months of life. The main cause of CNS is genetic def...

IPNA clinical practice recommendations for the diagnosis and management of children wit...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7316686
Pediatric Nephrology (Berlin, Germany); Trautmann A, Vivarelli M et. al.

May 10th, 2020 - Idiopathic nephrotic syndrome newly affects 1-3 per 100,000 children per year. Approximately 85% of cases show complete remission of proteinuria following glucocorticoid treatment. Patients who do not achieve complete remission within 4-6 weeks of...

Management of hepatitis C virus infection in patients with chronic kidney disease: posi...
https://doi.org/10.1007/s40620-018-0523-1 10.1111/ctr.12941 10.1111/tid.12696
Journal of Nephrology; Minutolo R, Aghemo A et. al.

Sep 27th, 2018 - Hepatitis C virus (HCV) infection is now considered a systemic disease due to the occurrence of extra-hepatic manifestations. Among these, the renal involvement is frequent. HCV infection, in fact, is strongly associated with proteinuria and chron...

A best-practice position statement on pregnancy after kidney transplantation: focusing ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6182355
Journal of Nephrology; Cabiddu G, Spotti D et. al.

Jun 28th, 2018 - Kidney transplantation (KT) is often considered to be the method best able to restore fertility in a woman with chronic kidney disease (CKD). However, pregnancies in KT are not devoid of risks (in particular prematurity, small for gestational age ...

A best practice position statement on the role of the nephrologist in the prevention an...
https://doi.org/10.1007/s40620-017-0390-1
Journal of Nephrology; Piccoli GB, Cabiddu G et. al.

Apr 24th, 2017 - Preeclampsia (PE) is a protean syndrome causing a transitory kidney disease, characterised by hypertension and proteinuria, ultimately reversible after delivery. Its prevalence is variously estimated, from 3 to 5% to 10% if all the related disorde...

see more →

Drugs  518 results see all →

Clinicaltrials.gov  259 results

A Study of Guselkumab in Participants With Active Lupus Nephritis
https://clinicaltrials.gov/ct2/show/NCT04376827

Nov 24th, 2021 - Guselkumab is a monoclonal antibody (mAb) that binds to human interleukin (IL)-23 with high affinity and blocks binding of extracellular IL-23 to cell surface IL-23 receptor, inhibiting IL 23 specific intracellular signaling and subsequent activat...

The FOrMe Registry (The German Focal Segmental Glomerulosclerosis and Minimal Change Disease Registry)
https://clinicaltrials.gov/ct2/show/NCT03949972

Nov 22nd, 2021 - Idiopathic Nephrotic Syndrome is characterized by proteinuria, volume retention, hyperlipidemia, hypoalbuminemia. As Minimal Change Disease (MCD) represents by far the most prevalent underlying diagnosis in children older than 1 year, a kidney bio...

Study of Efficacy and Safety of LNP023 in Primary IgA Nephropathy Patients
https://clinicaltrials.gov/ct2/show/NCT04578834

Nov 17th, 2021 - This trial is a multicenter, randomized, double-blind, placebo controlled parallel group study. The purpose of the study is to evaluate the efficacy and safety of LNP023 compared to placebo on proteinuria reduction and slowing disease progression ...

Dexamedtomidine in Control of Intracranial Pressure in Preeclampsia
https://clinicaltrials.gov/ct2/show/NCT05119101

Nov 12th, 2021 - Preeclampsia remains one of the leading causes of maternal morbidity and mortality in pregnant women. preeclampsia occurs in 7% to 8% of pregnancies. Preeclampsia is a multisystem progressive disorder characterized by the new onset of hypertension...

Proteinuria in Pre and Post Transplant
https://clinicaltrials.gov/ct2/show/NCT01094327

Nov 11th, 2021 - This study will retrospectively review patient's medical records for protein in the urine, blood creatinine and kidney biopsy results. Also character of the fluid used to flush the kidney before transplant will be analyzed.

see more →

News  487 results

Rituximab, Cyclophosphamide Similar for Inducing EGPA Remission
https://www.medscape.com/viewarticle/963134

Nov 17th, 2021 - Rituximab didn't perform any worse or better at inducing remission after a year in patients with eosinophilic granulomatosis with polyangiitis (EGPA) than did conventional treatment with cyclophosphamide in the phase 3 REOVAS trial conducted in Fr...

Surufatinib Induces Robust Responses in US Patients with Extrapancreatic and Pancreatic NETs
https://www.onclive.com/view/surufatinib-induces-robust-responses-in-us-patients-with-extrapancreatic-and-pancreatic-nets

Nov 16th, 2021 - Surufatinib demonstrated strong antitumor activity along with a manageable safety profile in heavily treated US patients with progressive extrapancreatic neuroendocrine tumors (ep-NETs) or pancreatic NETs (pNETs), according to interim phase 1 data...

ADVOCATE: Avacopan Shows Renal Benefits in ANCA Vasculitis
https://www.medscape.com/viewarticle/963050

Nov 16th, 2021 - Treatment of antineutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis and renal disease with the oral C5a receptor inhibitor avacopan (Tavneos, ChemoCentryx) provides significant recovery of kidney function compared with prednisone, pa...

KEYNOTE-826: Immune Checkpoint Inhibition in Metastatic Cervical Cancer
https://www.onclive.com/view/keynote-826-immune-checkpoint-inhibition-in-metastatic-cervical-cancer

Nov 10th, 2021 - Transcript: Bradley Monk, MD, FACOG, FACS: We want to do more. The survival, Krish, for the GOG 240 trial was about, 16.5, 17 months? Is that what you said? Krishnansu S. Tewari, MD:The median was 17 months. Bradley Monk, MD, FACOG, FACS: T...

Checkpoint Blockade Moves Needle in Molecularly Driven Endometrial Cancer Paradigm
https://www.onclive.com/view/checkpoint-blockade-moves-needle-in-molecularly-driven-endometrial-cancer-paradigm

Nov 4th, 2021 - The management of endometrial cancer, a molecularly driven malignancy with 4 distinct subtypes, has witnessed significant progress with recent regulatory approvals of checkpoint blockade alone and in combination, said Bhavana Pothuri, MD, MS, in a...

see more →

Patient Education  7 results see all →